Page 4 - Flipbook
P. 4

Learning Objectives

                At the end of this presentation, participants will be able to:

                • Describe Canadian guidelines on the management of muscle-invasive bladder

                   cancer (MIBC) in order to maximize cure rates

                • Identify patients with MIBC who are eligible for neoadjuvant and

                   adjuvant therapy using a multidisciplinary and patient-centered approach

                • Assess the latest clinical trial data investigating immune checkpoint inhibitors

                   in the neoadjuvant and adjuvant settings in patients with MIBC
   1   2   3   4   5   6   7   8   9